Literature DB >> 9397117

A simplified protocol for pessary management.

V Wu1, S A Farrell, T F Baskett, G Flowerdew.   

Abstract

OBJECTIVE: To evaluate a simplified protocol for pessary management.
METHODS: Women with symptomatic pelvic organ prolapse who opted for pessaries were enrolled in a prospective simplified protocol for pessary management. After the initial pessary fitting, they were seen at 2 weeks for reexamination and thereafter at 3- to 6-month intervals.
RESULTS: One hundred ten women (mean age 65 years) were enrolled, and 81 (74%) of them were fitted successfully with a pessary. Life-table analysis showed that 66% of those who used a pessary for more than 1 month were still users after 12 months and 53% were still users after 36 months. The severity of pelvic prolapse did not predict the likelihood of pessary failure except in cases of complete vaginal eversion. Patients complaining of stress incontinence were less likely to have a successful pessary fitting and more likely to opt for surgery. Current hormone use and substantial perineal support do not predict greater likelihood of pessary fitting success. No serious complications from using the pessary were observed in the study sample.
CONCLUSION: Stringent guidelines calling for frequent pelvic examinations during pessary use can be relaxed safely. Pessaries can be offered as a safe long-term option for the management of pelvic prolapse.

Entities:  

Mesh:

Year:  1997        PMID: 9397117     DOI: 10.1016/s0029-7844(97)00481-x

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  35 in total

1.  Impact on quality of life after ring pessary use for pelvic organ prolapse.

Authors:  Tarinee Manchana; Suvit Bunyavejchevin
Journal:  Int Urogynecol J       Date:  2012-01-06       Impact factor: 2.894

Review 2.  Genital prolapse in women.

Authors:  Joseph Loze Onwude
Journal:  BMJ Clin Evid       Date:  2012-03-14

3.  Pessary use in pelvic organ prolapse and urinary incontinence.

Authors:  Keisha A Jones; Oz Harmanli
Journal:  Rev Obstet Gynecol       Date:  2010

Review 4.  An integrative review and severity classification of complications related to pessary use in the treatment of female pelvic organ prolapse.

Authors:  Marwa Abdulaziz; Lynn Stothers; Darren Lazare; Andrew Macnab
Journal:  Can Urol Assoc J       Date:  2015 May-Jun       Impact factor: 1.862

5.  Safety and effectiveness of Colpexin Sphere in the treatment of pelvic organ prolapse.

Authors:  James Chivian Lukban; Oscar A Aguirre; G Willy Davila; Peter K Sand
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-11-19

6.  Diagnosis and Therapy of Female Pelvic Organ Prolapse. Guideline of the DGGG, SGGG and OEGGG (S2e-Level, AWMF Registry Number 015/006, April 2016).

Authors:  K Baeßler; T Aigmüller; S Albrich; C Anthuber; D Finas; T Fink; C Fünfgeld; B Gabriel; U Henscher; F H Hetzer; M Hübner; B Junginger; K Jundt; S Kropshofer; A Kuhn; L Logé; G Nauman; U Peschers; T Pfiffer; O Schwandner; A Strauss; R Tunn; V Viereck
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-12       Impact factor: 2.915

Review 7.  Genital prolapse in women.

Authors:  Joseph Loze Onwude
Journal:  BMJ Clin Evid       Date:  2009-11-30

8.  Vaginal pessaries in managing women with pelvic organ prolapse and urinary incontinence: patient characteristics and factors contributing to success.

Authors:  Lesley-Ann M Hanson; Jane A Schulz; Catherine G Flood; Bonita Cooley; Florence Tam
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-07-26

9.  Survey of the characteristics and satisfaction degree of the patients using a pessary.

Authors:  Sang Wook Bai; Bo Sung Yoon; Ja Young Kwon; Jong Seung Shin; Sei Kwang Kim; Ki Hyun Park
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004-12-01

10.  Patterns of pessary care and outcomes for medicare beneficiaries with pelvic organ prolapse.

Authors:  Marianna Alperin; Aqsa Khan; Emily Dubina; Christopher Tarnay; Ning Wu; Chris L Pashos; Jennifer T Anger
Journal:  Female Pelvic Med Reconstr Surg       Date:  2013 May-Jun       Impact factor: 2.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.